Olanzapine 5 mg plus standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting (J-FORCE): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Published Online: 2020-02-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Daisuke Takei•Hideaki Mizutani•Hironobu Hashimoto•Kazuhisa Nakashima•Koki Mizukami•Masahiko Nakao•Masakazu Abe•Michiru Sakurai•Noboru Yamamoto•Osamu Tokuyama•Sadamoto Zenda•Satoru Iwasa•Takako Yanai Takahashi•Takuhiro Yamaguchi•Yasuhiko Sakata•Yosuke Uchitomi•Yuichiro Ohe•Yukari Hoshina
